Sign in

CIK 0000200406

  • Large accelerated filer

JOHNSON & JOHNSON

Sign in to watch
Ticker
JNJ
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Jan 3
Incorporated
NJ
Entity type
Operating
EIN
221024240
Phone
+1 732-524-2455
Business address
ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
Former names
JOHNSON & JOHNSON ET AL
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$12,947,986
in 2 filings

Net −$12,947,986. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-04-27 Adamczyk Darius Director Grant or award · Deferred Share Units +1,193.98 2,258.52
2023-03-07 Washington A. Eugene Director Grant or award · Deferred Share Units +201.41 $155.16 $31K 28,569.45
2023-03-07 HEWSON MARILLYN A Director Grant or award · Deferred Share Units +233.63 $155.16 $36K 6,430.93
2023-03-06 Swanson James D. Sale −1,061.68 $154.66 $164K 9,215.32
2023-02-13 Wolk Joseph J Exec VP, CFO Grant or award +20,693 58,975.2
2023-02-13 Wolk Joseph J Exec VP, CFO Shares withheld for taxes −8,578 $162.01 $1.4M 50,397.2
2023-02-13 Wolk Joseph J Exec VP, CFO Grant or award · Employee Stock Options (Right to Buy) +88,334 88,334
2023-02-13 Wolk Joseph J Exec VP, CFO Grant or award · Restricted Share Units +5,338 5,338
2023-02-13 Wengel Kathryn E EVP, Chief TO and Risk Officer Grant or award +10,839 83,289.87
2023-02-13 Wengel Kathryn E EVP, Chief TO and Risk Officer Shares withheld for taxes −4,891 $162.01 $792K 78,398.87
2023-02-13 Wengel Kathryn E EVP, Chief TO and Risk Officer Grant or award · Employee Stock Options (Right to Buy) +32,317 32,317
2023-02-13 Wengel Kathryn E EVP, Chief TO and Risk Officer Grant or award · Restricted Share Units +1,953 1,953
2023-02-13 Taubert Jennifer L EVP, WW Chair, Pharmaceuticals Grant or award +21,422 150,159
2023-02-13 Taubert Jennifer L EVP, WW Chair, Pharmaceuticals Shares withheld for taxes −10,569 $162.01 $1.7M 139,590
2023-02-13 Taubert Jennifer L EVP, WW Chair, Pharmaceuticals Grant or award · Employee Stock Options (Right to Buy) +64,634 64,634
2023-02-13 Taubert Jennifer L EVP, WW Chair, Pharmaceuticals Grant or award · Restricted Share Units +3,906 3,906
2023-02-13 Swanson James D. Grant or award +3,228 11,195
2023-02-13 Swanson James D. Shares withheld for taxes −918 $162.01 $149K 10,277
2023-02-13 Swanson James D. Grant or award · Employee Stock Options (Right to Buy) +22,191 22,191
2023-02-13 Swanson James D. Grant or award · Restricted Share Units +1,341 1,341

Page 35 of 60 · 1,189 trades